A/H1N1 influenza vaccine (adjuvanted, swine-origin)

influenza vaccine, A/H1N1, monovalent, adjuvanted · Novartis Vaccines

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for A/H1N1 influenza vaccine (adjuvanted, swine-origin), covering 2016-12-01 to 2016-12-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity, Safety and Tolerability of Two Doses of Adjuvanted and Non-adjuvanted Swine Origin A/H1N1 Monovalent Influenza Vaccine in Healthy Subjects 18 or More Years of Age [Phase 3]

See pricing